Background Optimizing immunosuppression in lung transplant recipients (LTR) is crucially important minimizing the risk of infection and rejection. Quantiferon®-Monitor (QFM) a candidate immune function biomarker which has not yet been rigorously evaluated setting. The aim this prospective cohort study was to explore relationships between QFM results, immunosuppression, infection/rejection LTR. ...

BACKGROUND Urinary tract infection is the most common infectious disease requiring hospitalisation following renal transplantation. However, the risk and outcome of post-transplant pyelonephritis remains unclear. METHODS This population-based cohort study was conducted from 1 January 1990 to 31 December 2009. Each member of a Danish population-based, nationwide cohort of first-time renal tran...

BACKGROUND Improvements in renal allograft outcomes have permitted kidney transplantation after prior kidney allograft failure as well as after nonrenal solid organ transplantation. This study compares renal allograft outcomes in the 3 groups, that is, primary, repeat, and kidney after nonrenal solid organ transplantation, where transplant group was coded as a time-dependent variable. METHODS...

introductio: hematopoietic stem cell transplants (hsct) are considered as treatment options for patients with solid tumors. transplant numbers have changed significantly over the last decade. we have done autologous and allogeneic hsct for treatment of solid tumor patients in our center. methods: in order to show the transplant effect on solid tumor treatment, we collected data from 71 patients...

background: monitoring of phenotypic characteristics of t-lymphocytes in peripheral blood is commonly performed to give the clinical parameters in the management of kidney transplant recipients.   objective: to predict rejection in renal transplantation by immune parameters. methods: 16 non-diabetic kidney transplant candidates (4 females and 12 males, age = 20-65 yr, first time transplant) wer...

BACKGROUND Management of hepatocellular carcinoma (HCC) in the Model for End-Stage Liver Disease (MELD) exception era remains regionally variable. Outcomes were compared for patients undergoing transplant versus resection at a single institution in a UNOS region with short wait times for organ availability. METHODS All patients who underwent resection of HCC from January 2000 to August 2012 a...

Liver transplantation is a life-extending procedure for patients with end-stage liver disease (ESLD), post-transplant infections continue to be leading cause of morbidity and mortality. Infection risk varies over time, issues most commonly related transplant surgery nosocomial in the early period. Because increased burden immunosuppression, opportunistic become more common between 1 12 months p...

background hospital personnel of services related to donation and transplantation process play a fundamental role in the development of transplantation. objectives the aim of this study was to investigate the attitude toward living liver donation (lld) among hospital personnel from services related to donation and transplantation in hospital centers in spain and latin america. materials and met...

objectives the aim of this study was to evaluate the efficacy, safety, and tolerability of sofosbuvir and ribavirin in ldlt recipients with recurrent hcv genotype 4. patients and methods thirty-nine egyptian ldlt recipients were treated for recurrent hcv after ldlt with nucleos(t)ide analog ns5b polymerase inhibitor, sofosbuvir, and ribavirin without pegylated interferon for 6 months (november ...